Tian, T.; Han, H.; Huang, J.; Ma, J.; Ran, R.
DBI as a Novel Immunotherapeutic Candidate in Colorectal Cancer: Dissecting Genetic Risk and the Immune Landscape via GWAS, eQTL, and pQTL. Biomedicines 2025, 13, 1115.
https://doi.org/10.3390/biomedicines13051115
AMA Style
Tian T, Han H, Huang J, Ma J, Ran R.
DBI as a Novel Immunotherapeutic Candidate in Colorectal Cancer: Dissecting Genetic Risk and the Immune Landscape via GWAS, eQTL, and pQTL. Biomedicines. 2025; 13(5):1115.
https://doi.org/10.3390/biomedicines13051115
Chicago/Turabian Style
Tian, Ting, Huan Han, Jingtao Huang, Jun’e Ma, and Ruoxi Ran.
2025. "DBI as a Novel Immunotherapeutic Candidate in Colorectal Cancer: Dissecting Genetic Risk and the Immune Landscape via GWAS, eQTL, and pQTL" Biomedicines 13, no. 5: 1115.
https://doi.org/10.3390/biomedicines13051115
APA Style
Tian, T., Han, H., Huang, J., Ma, J., & Ran, R.
(2025). DBI as a Novel Immunotherapeutic Candidate in Colorectal Cancer: Dissecting Genetic Risk and the Immune Landscape via GWAS, eQTL, and pQTL. Biomedicines, 13(5), 1115.
https://doi.org/10.3390/biomedicines13051115